What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures, participated…
Continue Reading
LRVHealth, McKesson Ventures, Novartis, Hearst Ventures, Onco360, and HealthX Ventures Join Investment Round to Redefine Specialty Patient Access and Onboarding
RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability,…
